A new Master of Science in Regulatory Affairs (MSRA) has launched at Chapman University School of Pharmacy, and will welcome its first cohort in fall 2026. This career-focused graduate degree is designed to train the rising generation of professionals driving biopharmaceutical and medical innovations efficiently and safely to international markets.

“The MSRA program uniquely blends science, policy, and legal standards, ensuring that innovative healthcare solutions reach patients safely and effectively,” says Marc Fleming, Ph.D., the Chair of the Pharmaceutical Economics and Policy department and who has been foundational to the program. “With our Rinker Health Science campus being located in one of the leading biotechnology regions, our MSRA positions students to make an immediate impact in public health.”

Industry-Focused Design and Learning

A satellite campus, the Harry and Diane Rinker Health Science Campus, neighbors major industry leaders in Irvine, California, including Edwards Lifesciences, Johnson & Johnson, and Masimo. MSRA students will have exceptional access to networking events, and mentorship opportunities that will supplement classroom learning. Even in the classroom, many courses will be taught by adjunct faculty who are seasoned industry professionals with decades of experience bringing hundreds of products to patients—from discovery through post-market approval. The 30-credit program covers international and U.S. regulatory frameworks, FDA regulations, and emerging innovations in digital health.

Core courses include Biologic and Biosimilar Applications, Medical Device and Digital Health Regulations, and Biomedical Products Marketing, Pricing, and Reimbursement, and are supplemented with other elective credits to tailor their education to career goals.

Students will also complete experiential coursework. Simulations that mimic real-world regulatory workflows and decision-making environments will create portfolios for graduates that demonstrate career-ready skills.

Advancing Public Trust in Healthcare 

Graduates of the MSRA will be equipped for impactful careers in roles such as Regulatory Affairs Specialist, Quality Assurance Analyst, Compliance Officer, and Clinical Trials Coordinator, which average a national salary of $136,550 (U.S. Department of Labor, 2025).

Our Advisory Board, composed of industry leaders from organizations including AbbVie and Applied Medical, helps ensure the curriculum remains career-focused, forward-thinking, and grounded in real-world practice.

Building on Chapman University School of Pharmacy’s long-standing commitment to patient safety, healthcare innovation, and scientific integrity, the MSRA program empowers graduates to advance public trust and drive responsible innovation that improves patient outcomes worldwide.

Interested in learning more about the MSRA? Click here to visit the program’s website.